Functional deficiency in endogenous interleukin‐1 receptor antagonist in patients with febrile infection‐related epilepsy syndrome

OBJECTIVE: We recently reported successful treatment of a child with febrile infection‐related epilepsy syndrome (FIRES), a subtype of new onset refractory status epilepticus, with the recombinant interleukin‐1 (IL1) receptor antagonist (IL1RA) anakinra. On this basis, we tested whether endogenous I...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarkson, Benjamin D. S., LaFrance‐Corey, Reghann G., Kahoud, Robert J., Farias‐Moeller, Raquel, Payne, Eric T., Howe, Charles L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450741/
https://www.ncbi.nlm.nih.gov/pubmed/30779222
http://dx.doi.org/10.1002/ana.25439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450741/
https://www.ncbi.nlm.nih.gov/pubmed/30779222
http://dx.doi.org/10.1002/ana.25439

Ejemplares similares